Regeneron 1331 Kinetics Sub-Study HoFH

Completed · Not applicable

Conditions studied: Hypercholesterolemia, Familial

In brief

To evaluate the lipoprotein kinetics of subjects enrolled in the R1500-CL-1331 clinical trial (NCT02265952) to assess the mechanism by which the evinacumab may affect lipid levels in HoFH subjects.

Key facts

Study ID

NCT04722068

Run by

University of Pennsylvania

People needed

4

Starts

2016-10-07

Expected to finish

2021-01-01

Last updated by the study team

2021-05-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• Department of Vascular Medicine Amsterdam UMC — Amsterdam, AZ, Netherlands

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.